Cost-Effectiveness of Vaccines and Public Health
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccines and Public Health".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 753
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue, Cost-Effectiveness of Vaccines and Public Health, focuses on cost-effectiveness assessments of vaccines and their use in assessing the public health value of vaccines and vaccination. Authors are encouraged to submit cost-effectiveness studies of novel vaccines or vaccine candidates for neglected, emerging, reemerging, or even major infectious diseases that consider public health impact. Authors are also encouraged to submit reviews of such studies. Analyses based on trial data are accepted. Authors are also encouraged to submit empirical or methodological studies that augment traditional cost-effectiveness analyses of vaccines to assess their full public health value. These studies can include other valuation methods that supplement cost-effectiveness, such as valuing distributional consequences, economic welfare impacts, and impacts on life expectancy. They can also include studies extending cost-effectiveness analyses, such as extended cost-effectiveness, which incorporates equity and distributional considerations. Authors are encouraged to submit studies of novel methods of translating traditional cost-effectiveness analyses to realize greater public health value. These studies can include vaccine investment analyses, health systems impact analyses, assessments of vaccination strategies, and even public health interventions that improve vaccination outcomes.
Dr. Sachin A. Silva
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cost-effectiveness
- public health value
- vaccines
- valuation
- vaccination
- immunization
- benefit–cost
- welfare
- extended cost-effectiveness
- QALYs
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
